Similar articles for PMID: 33323363

Year	Number of Results
2003	1
2020	44
2021	17
2023	0

1

Update to coagulopathy in COVID-19: Manifestations and management.

Mucha SR, Dugar S, McCrae K, Joseph D, Bartholomew J, Sacha GL, Militello M. Mucha SR, et al. Cleve Clin J Med. 2021 Jun 2. doi: 10.3949/ccjm.87a.ccc024-up. Online ahead of print. Cleve Clin J Med. 2021. PMID: 33323363 Free article.

2

Coagulopathy in COVID-19: Manifestations and management.

Mucha SR, Dugar S, McCrae K, Joseph D, Bartholomew J, Sacha GL, Militello M. Mucha SR, et al. Cleve Clin J Med. 2020 Jul 31;87(8):461-468. doi: 10.3949/ccjm.87a.ccc024. Cleve Clin J Med. 2020. PMID: 32409435 Free article.

3

D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.

Eljilany I, Elzouki AN. Eljilany I, et al. Vasc Health Risk Manag. 2020 Nov 13;16:455-462. doi: 10.2147/VHRM.S280962. eCollection 2020. Vasc Health Risk Manag. 2020. PMID: 33223833 Free PMC article. Review.

4

COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.

Manolis AS, Manolis TA, Manolis AA, Papatheou D, Melita H. Manolis AS, et al. J Cardiovasc Pharmacol Ther. 2021 Jan;26(1):12-24. doi: 10.1177/1074248420958973. Epub 2020 Sep 14. J Cardiovasc Pharmacol Ther. 2021. PMID: 32924567 Free PMC article. Review.

5

An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study.

Ogawa F, Oi Y, Nakajima K, Matsumura R, Nakagawa T, Miyagawa T, Abe T, Takeuchi I. Ogawa F, et al. Thromb J. 2021 Apr 20;19(1):26. doi: 10.1186/s12959-021-00280-z. Thromb J. 2021. PMID: 33879177 Free PMC article.

6

Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.

Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Obi AT, et al. J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):23-35. doi: 10.1016/j.jvsv.2020.08.030. Epub 2020 Sep 8. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 32916371 Free PMC article. Review.

7

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.

Artifoni M, Danic G, Gautier G, Gicquel P, Boutoille D, Raffi F, Néel A, Lecomte R. Artifoni M, et al. J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z. J Thromb Thrombolysis. 2020. PMID: 32451823 Free PMC article.

8

Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.

Dujardin RWG, Hilderink BN, Haksteen WE, Middeldorp S, Vlaar APJ, Thachil J, Müller MCA, Juffermans NP. Dujardin RWG, et al. Thromb Res. 2020 Dec;196:308-312. doi: 10.1016/j.thromres.2020.09.017. Epub 2020 Sep 15. Thromb Res. 2020. PMID: 32977128 Free PMC article.

9

Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients.

Eriksson O, Hultström M, Persson B, Lipcsey M, Ekdahl KN, Nilsson B, Frithiof R. Eriksson O, et al. Thromb Haemost. 2020 Dec;120(12):1720-1724. doi: 10.1055/s-0040-1715835. Epub 2020 Sep 1. Thromb Haemost. 2020. PMID: 32871607 Free PMC article.

10

Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment.

Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Gąsecka A, et al. Cardiovasc Drugs Ther. 2021 Apr;35(2):215-229. doi: 10.1007/s10557-020-07084-9. Epub 2020 Oct 19. Cardiovasc Drugs Ther. 2021. PMID: 33074525 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed